NCT06694025View on ClinicalTrials.gov

Post-marketing Surveillance Study for the Safety of Efluelda Tetra Pre-filled Syringe.

RecruitingOBSERVATIONAL
Enrollment

670

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

December 5, 2030

Study Completion Date

December 5, 2030

Conditions
ImmunizationInfluenza (Healthy Volunteers)
Interventions
BIOLOGICAL

Efluelda Tetra Pre-filled syringe

Suspension for injection in a pre-filled syringe

Trial Locations (1)

07441

RECRUITING

Investigational Site Number : 001, Seoul

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT06694025 - Post-marketing Surveillance Study for the Safety of Efluelda Tetra Pre-filled Syringe. | Biotech Hunter | Biotech Hunter